Company research
Endexx Corp
CIK 1109486Updated Sep 25, 2026
SecurityEDXC · OTC · equity
Historical securities (1)
MICRD · OTC · equity · closed Apr 25, 2025Name history
PANAMED CORP · through Dec 1, 2020MICRON SOLUTIONS INC · through Mar 12, 2002
EDXC price & chart
Loading TradingView…
OTC:EDXC on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 13,278,390Source | 1,759,913Source |
| Property, Plant and Equipment, NetUSD | 48,005Source | 449,661Source |
| GoodwillUSD | 9,807,361Source | — |
| Current assets: | ||
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 570,406Source | 50,755Source |
| Inventory, NetUSD | 777,912Source | 920,812Source |
| Assets, CurrentUSD | 3,372,194Source | 1,034,082Source |
| Operating Lease, Right-of-Use AssetUSD | 34,160Source | — |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 22,972,050Source | 11,747,054Source |
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | 50,138Source | 48,631Source |
| Additional Paid in CapitalUSD | 32,914,424Source | 29,477,818Source |
| Retained Earnings (Accumulated Deficit)USD | -44,398,312Source | -39,513,844Source |
| Stockholders' Equity Attributable to ParentUSD | -11,433,568Source | -9,987,141Source |
| Liabilities and EquityUSD | 13,278,390Source | 1,759,913Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 18,384,332Source | 11,498,854Source |
| Operating Lease, Liability, CurrentUSD | 35,656Source | — |
| Accounts Payable, CurrentUSD | 2,647,533Source | 1,020,464Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -260,092Source | — |
| Additional Financial Items | ||
| Accrued Liabilities, CurrentUSD | 172,711Source | 43,469Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -5,144,560Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation, Depletion and AmortizationUSD | 20,606Source | 20,400Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 455,800Source | 721,021Source |
| Changes in operating assets and liabilities: | ||
| Increase (Decrease) in Accounts ReceivableUSD | 876,280Source | 21,314Source |
| Increase (Decrease) in InventoriesUSD | 35,442Source | 216,704Source |
| Increase (Decrease) in Accounts PayableUSD | 1,125,239Source | 599,982Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -2,088,304Source | -3,720,267Source |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -573,763Source | — |
| Cash flows from financing activities: | ||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 3,297,976Source | 3,736,484Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 635,909Source | 16,217Source |
| Supplemental disclosure of cash flow information: | ||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 75,061Source | 58,780Source |
| Additional Financial Items | ||
| Amortization of Debt Issuance Costs and DiscountsUSD | 1,857,046Source | 679,277Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | -4,397,706Source | 28,724Source |
| Gain (Loss) on Disposition of AssetsUSD | 423,950Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | 289,100Source | — |
| General and Administrative ExpenseUSD | 1,592,091Source | 859,904Source |
| GoodwillUSD | 9,807,361Source | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -4,884,468Source | -6,808,154Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -260,092Source | — |
| Nonoperating Income (Expense)USD | -1,227,746Source | -1,436,825Source |
| Operating ExpensesUSD | 5,109,924Source | 5,027,251Source |
| Proceeds from Issuance of Common StockUSD | — | 328,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 |
|---|---|---|
| Total RevenueUSD | 2,138,010Source | 650,515Source |
| Cost of Goods and Services Sold | — | — |
| Operating Income (Loss)USD | -3,916,814Source | -5,371,329Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -260,092Source | — |
| Net Income (Loss) Attributable to ParentUSD | -4,884,468Source | -6,808,154Source |
| Earnings Per Share, BasicUSD per share | -0.01Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 503,983,723Source | — |
| Additional Financial Items | ||
| Depreciation, Depletion and Amortization, NonproductionUSD | 20,606Source | 20,400Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | -4,397,706Source | 28,724Source |
| General and Administrative ExpenseUSD | 1,592,091Source | 859,904Source |
| Gross ProfitUSD | 1,193,110Source | -344,078Source |
| Interest ExpenseUSD | 1,241,853Source | 950,549Source |
| Labor and Related ExpenseUSD | 609,288Source | 637,493Source |
| Marketing and Advertising ExpenseUSD | 594,874Source | 1,778,073Source |
| Nonoperating Income (Expense)USD | -1,227,746Source | -1,436,825Source |
| Operating ExpensesUSD | 5,109,924Source | 5,027,251Source |
| Research and Development ExpenseUSD | 27,066Source | 10,145Source |